Edinburgh Research Explorer

Mechanism of action (MoA) study 3month oral dosing of Vilprisan or Ulipristal in patients with uterine fibroids scheduled for hystorectomy

Project: Research

StatusFinished
Effective start/end date1/09/1731/08/19
Total award£23,279.00
Funding organisationUK industry, commerce and public corporations
Period1/09/1731/08/19